The President of the Polish Office for the Registration of Medicinal Products, Medical Devices, and Biocidal Products issued two more Brexit related communiques....more
4/2/2019
/ Biotechnology ,
Imports ,
Licensing Rules ,
Life Sciences ,
Manufacturers ,
Marketing ,
Medical Devices ,
No-Deal Brexit ,
Pharmaceutical Industry ,
Poland ,
Regulatory Standards ,
Trade Policy ,
UK Brexit
On 1 March 2019, the President of the Polish Office for Registration of Medicinal Products, Medical Devices and Biocidal Products issued yet another communique concerning consequences of Brexit, this time with respect to the...more
3/5/2019
/ Biosimilars ,
EU ,
Healthcare ,
Life Sciences ,
Medical Devices ,
Medical Reimbursement ,
No-Deal Brexit ,
Pharmaceutical Industry ,
Poland ,
Regulatory Standards ,
UK ,
UK Brexit